The role of lncRNA OIP5-AS1 in cancer development and progression
- PMID: 35316453
- DOI: 10.1007/s10495-022-01722-3
The role of lncRNA OIP5-AS1 in cancer development and progression
Abstract
OIP5-AS1, a conserved lncRNA, has been reported to be involved in several biological and pathological processes, including oncogenesis. OIP5-AS1 exerts its oncogenic or antitumor functions via regulation of different miRNAs in various cancer types. In this review, we describe the dysregulation of OIP5-AS1 expression in a variety of human cancers. Moreover, we discuss the multiple functions of OIP5-AS1 in cancer, including in proliferation, apoptosis, autophagy, ferroptosis, cell cycle, migration, metastasis, invasion, epithelial to mesenchymal transition, angiogenesis, cancer stem cells and drug resistance. Furthermore, we provide a future perspective for OIP5-AS1 research. We conclude that targeting OIP5-AS1 might be a promising cancer therapy approach.
Keywords: Cancer; OIP5-AS1; Oncogene; Therapy; miRNAs.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
LncRNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) promotes the migration, invasion and epithelial-mesenchymal transition (EMT) through targeting miR-147a/insulin-like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and cell model.J Obstet Gynaecol Res. 2022 May;48(5):1222-1232. doi: 10.1111/jog.15209. Epub 2022 Mar 1. J Obstet Gynaecol Res. 2022. PMID: 35233882
-
Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA6.J Ovarian Res. 2022 Feb 16;15(1):25. doi: 10.1186/s13048-021-00937-3. J Ovarian Res. 2022. PMID: 35168644 Free PMC article.
-
Long non-coding RNA OIP5-AS1 serves as an oncogene in laryngeal squamous cell carcinoma by regulating miR-204-5p/ZEB1 axis.Naunyn Schmiedebergs Arch Pharmacol. 2020 Nov;393(11):2177-2184. doi: 10.1007/s00210-020-01811-7. Epub 2020 Feb 3. Naunyn Schmiedebergs Arch Pharmacol. 2020. PMID: 32009213
-
A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies.Biomed Pharmacother. 2021 May;137:111366. doi: 10.1016/j.biopha.2021.111366. Epub 2021 Feb 15. Biomed Pharmacother. 2021. PMID: 33601149 Review.
-
Stoichiometry of long noncoding RNA interactions with other RNAs: Insights from OIP5-AS1.Wiley Interdiscip Rev RNA. 2024 Mar-Apr;15(2):e1841. doi: 10.1002/wrna.1841. Wiley Interdiscip Rev RNA. 2024. PMID: 38576135 Review.
Cited by
-
Deciphering the Role of LncRNAs in Osteoarthritis: Inflammatory Pathways Unveiled.J Inflamm Res. 2024 Sep 20;17:6563-6581. doi: 10.2147/JIR.S489682. eCollection 2024. J Inflamm Res. 2024. PMID: 39318993 Free PMC article. Review.
-
LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma.Front Oncol. 2022 Jun 8;12:921929. doi: 10.3389/fonc.2022.921929. eCollection 2022. Front Oncol. 2022. PMID: 35756672 Free PMC article.
-
The landscape of human p53-regulated long non-coding RNAs reveals critical host gene co-regulation.Mol Oncol. 2023 Jul;17(7):1263-1279. doi: 10.1002/1878-0261.13405. Epub 2023 Mar 9. Mol Oncol. 2023. PMID: 36852646 Free PMC article.
-
Down-regulation of OIP5-AS1 inhibits obesity-induced myocardial pyroptosis and miR-22/NLRP3 inflammasome axis.Immun Inflamm Dis. 2023 Oct;11(10):e1066. doi: 10.1002/iid3.1066. Immun Inflamm Dis. 2023. PMID: 37904706 Free PMC article.
-
Dysregulated Long Non-coding RNAs in Myasthenia Gravis- A Mini-Review.Curr Mol Med. 2025;25(1):2-12. doi: 10.2174/0115665240281531231228051037. Curr Mol Med. 2025. PMID: 38192147 Review.
References
-
- Sun WL, Kang T, Wang YY et al (2019) Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410. Biosci Rep 39(1):395
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources